SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Repligen Corp (RGEN)
An SI Board Since February 1996
Posts SubjectMarks Bans Symbol
395 38 0 RGEN
Emcee:  Rajiv Hargunani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
320thanks! (eom)scaram(o)uche-1/6/2006
319I went looking and here's the link. It's from May 2004: the-scientist.cBiomaven-1/6/2006
318It was from <i>The Scientist</i>. But the link didn't work, so tBiomaven-1/6/2006
317wow, Perkel did a great job. thanks. where/when was that from??scaram(o)uche-1/6/2006
316Here's RGEN's other patent case: <i>Protein expression patent figBiomaven-1/6/2006
315<i>patent problems</i> Well at this point it's BMY that has theBiomaven-1/6/2006
314This company seems to have patent problems. Is this an ongoing battle with themthelaw-1/6/2006
313re: those buying didn't know the story There's too much upside buying Harvey Allen-1/6/2006
312<I>didn't know the story on RGEN and CTLA4-Ig / Orencia?</i> I Biomaven-1/6/2006
311<i>thought it would be down...</i> You'd have thought so. Maybnigel bates-1/6/2006
310I can't figure it out. RGEN is up substantially in pre-market but I thought Harvey Allen-1/6/2006
309Repligen sues Bristol over arthritis drug patent Fri Jan 6, 2006 06:55 AM ET NEWnigel bates-1/6/2006
308<i>Until FDA approval any Repligen/Bristol-Myers settlement was moot.</Biomaven-12/28/2005
307Until FDA approval any Repligen/Bristol-Myers settlement was moot. The Rodman aHarvey Allen-12/28/2005
306<i>Garren will be proven wrong as he has not read the following patents beBiomaven-12/27/2005
305Repligen had a chart at the annual meeting with royalties from BMY @ 2%, 4%, 6% Harvey Allen-12/27/2005
304More Yahoo posts ... ======================================== United States NavJohn McCarthy-12/27/2005
303Garren will be proven wrong as he has not read the following patents belonging tejgopher-12/27/2005
302Thank you, John, that does clarify everything, everything.tom pope-12/26/2005
301posts from the Yahoo Board .... <B>ONE</B> >>>>>>John McCarthy-12/26/2005
300And visions of sugarplums danced in their heads I don't think Garren ever stom pope-12/24/2005
299Dr. Garren said <i>Bristol-Myers (BMY) will file a BLA for CTLA4-Ig by yHarvey Allen-12/24/2005
298UPDATE 2-FDA OKs Bristol-Myers rheumatoid arthritis drug Fri Dec 23, 2005 07:55 scaram(o)uche-12/23/2005
297This is the original decision regarding RGEN REGENTS OF THE UNIV. OF MICH. v. Biceman1999-9/18/2005
296They like it. Press Release Source: Repligen Corporation Repligen Reports Firtom pope-7/27/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News